1,852 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BRKR

Bruker
US$70.443.2%12.8%US$10.2bUS$79.74PE30.3xE20.8%0.3%

CRL

Charles River Laboratories International
US$198.26-5.4%1.5%US$10.0bUS$224.01PE23.7xE12.7%n/a

MEDP

Medpace Holdings
US$326.26-11.6%32.4%US$9.9bUS$397.25PE29.7xE13.5%n/a

QGEN

Qiagen
US$45.02-1.3%10.0%US$9.8bUS$50.97PE137.6xE37.1%n/a

1801

Innovent Biologics
HK$46.609.4%21.8%HK$76.0bHK$58.63PS9.2xE59.4%n/a

300122

Chongqing Zhifei Biological Products
CN¥27.8234.3%-42.8%CN¥66.6bCN¥37.14PE11xE22.3%2.9%

4151

Kyowa Kirin
JP¥2,572.50-19.8%-1.2%JP¥1.4tJP¥3,362.50PE13.9xE3.0%2.3%

ALKEM

Alkem Laboratories
₹6,184.601.6%71.5%₹741.0b₹5,583.24PE36xE11.3%0.6%

BIO

Bio-Rad Laboratories
US$332.10-3.6%-6.7%US$8.9bUS$380.17PS3.6xE51.6%n/a

ZEAL

Zealand Pharma
DKK 830.50-9.5%176.8%DKK 58.9bDKK 1,022.29PS160.1xE20.7%n/a

ROIV

Roivant Sciences
US$11.57-2.9%-7.8%US$8.7bUS$16.94PE1.8xE-55.6%n/a

1177

Sino Biopharmaceutical
HK$3.7010.1%30.7%HK$67.4bHK$4.65PE28.4xE13.5%1.6%

688506

Sichuan Biokin PharmaceuticalLtd
CN¥163.103.2%69.9%CN¥60.5bCN¥226.42PE15.5xE-95.8%0%

2269

WuXi Biologics (Cayman)
HK$15.9819.4%-65.0%HK$65.6bHK$19.38PE22.5xE18.9%n/a

300896

Imeik Technology DevelopmentLtd
CN¥196.3342.0%-29.6%CN¥59.1bCN¥264.39PE29.3xE22.3%0%

1093

CSPC Pharmaceutical Group
HK$5.6513.2%-1.6%HK$63.6bHK$7.96PE10xE2.2%5.7%

600196

Shanghai Fosun Pharmaceutical (Group)
CN¥25.1512.6%-12.1%CN¥57.3bCN¥27.29PE36.5xE29.7%1.1%

LEGN

Legend Biotech
US$46.85-7.8%-30.4%US$8.0bUS$82.98PS18.9xE63.7%n/a

ITCI

Intra-Cellular Therapies
US$73.21-4.9%36.1%US$7.9bUS$96.13PS13.7xE64.4%n/a

RGEN

Repligen
US$147.181.0%-8.1%US$7.8bUS$193.82PS13.7xE85.3%n/a

ORNBV

Orion Oyj
€49.555.0%33.1%€6.9b€47.17PE30xE13.1%3.3%

9926

Akeso
HK$67.402.9%87.2%HK$58.4bHK$65.80PS28.1xE54.5%n/a

RVMD

Revolution Medicines
US$43.86-5.0%55.3%US$7.5bUS$59.21PS9873.8xE12.8%n/a

999

China Resources Sanjiu Medical & Pharmaceutical
CN¥43.2813.8%12.3%CN¥52.3bCN¥54.95PE16.5xE10.1%2.7%
Page 4 of 78
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.